The Pirbright Institute, working in collaboration with the University of Oxford, have successfully shown that two doses of the ChAdOx1 nCoV-19 (AZD1222) vaccine produce a greater antibody response than a single dose in pigs. The emergence and subsequent spread of SARS-CoV-2 has caused a global...
Four mutations in bird flu viruses allow them to escape human antiviral drugs without compromising their fitness, studies at The Pirbright Institute have revealed. If flu strains with these mutations make the jump from birds to humans, available options for prevention and treatment could be limited...
Understanding how long a disease can be transmitted for is a cornerstone in preventing and controlling outbreaks, particularly when there is more than one route of infection. Scientists at The Pirbright Institute and Wageningen Bioveterinary Research have demonstrated that environments contaminated...
A team of researchers at The Pirbright Institute have used genetic engineering to disable the chikungunya virus genome in mosquito cells. With further development, the technology could help researchers to engineer disease resistant mosquitoes, which would make them unable to spread chikungunya...
Two recent studies from The Pirbright Institute and the University of Edinburgh’s Roslin Institute show that two vaccines against specific strains of infectious bronchitis virus (IBV) do not offer complete protection against a third strain, and that this may be partly down to the temperature range...
Pirbright's longstanding expertise in viral diseases is helping us to provide vital services and information that will help to tackle the life changing pandemic caused by COVID-19.
Our Coronavirus Hub provides an overview of how the Institute is aiding the pandemic response, including Pirbright's COVID-19 research on vaccines, understanding how the virus works, and exploring diagnostic solutions, as well as the support we are providing to the UK diagnostic effort.
We work collaboratively with stakeholders globally, including research and academic institutions, government ministries and agencies, multilateral organisations, non-government organisations (NGOs) that range from big international charities to local advocacy groups, as well as philanthropic foundations and commercial companies.
Our innovative research into viruses of farm animals and those that spread from animals to people is possible with new state-of-the-art facilities including the BBSRC National Virology and Vaccinology Centres. Find out more about our campus.
® The Pirbright Institute 2020 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.
